Uber Misses on Profit Outlook; Lilly Sees Surging Sales; Chipotle Projects Flat Growth
Feb 4, 2026
News on a soft profit outlook and a bold move into driverless taxis at a major ride-hailing firm. A pharmaceutical giant sees surging sales thanks to weight-loss drugs. A fast-casual chain warns of flat sales growth and the impact of changing consumer behavior. Talks also touch on takeover rumors boosting a chipmaker's stock.
04:33
forum Ask episode
web_stories AI Snips
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
insights INSIGHT
Uber's Soft Profit Signal
Uber's profit outlook and Q1 adjusted EBITDA came in light, signaling softer near-term profitability.
The stock reacted down sharply as investors parsed weaker profit guidance despite continued investment in robo-taxis.
insights INSIGHT
Lilly Dominates GLP-1 Sales
Eli Lilly reported strong Q4 results and forecast top-line growth, driven by GLP-1 weight-loss drugs.
Manjaro and ZepBound produced $11.5 billion in sales and lifted Lilly above peers amid Novo Nordisk weakness.
insights INSIGHT
Chipotle's Sales Stagnation
Chipotle posted its first annual drop in comparable sales and guided to about flat comps for the year.
The company faces headwinds from GLP-1s reducing appetite and from consumer sensitivity to higher menu prices.
Get the Snipd Podcast app to discover more snips from this episode
Today's biggest winners and losers in the stock market.
On this episode of Stock Movers: - Uber Technologies (UBER) gave a weak profit outlook and promoted an outspoken driverless-vehicle bull to be its new chief financial officer, signaling further investment in a closely watched area of the ride-hailing company’s business. The executive, Balaji Krishnamurthy, has been with Uber for more than six years and is currently vice president of strategic finance and investor relations. He will replace current CFO Prashanth Mahendra-Rajah, who is leaving for another opportunity after less than three years at the company, according to a regulatory filing published Wednesday. The outgoing CFO will step down from his post on Feb. 16 and stay on as a senior finance adviser through July 1, the filing said. - Eli Lilly & Co (LLY) provided an upbeat sales forecast for the year Wednesday as strong demand for its weight loss drug cemented its position at the top of the obesity market.The guidance was a sharp contrast to rival Novo Nordisk A/S, which warned investors Tuesday that its sales could drop as much as 13% this year on intensifying price competition in the weight loss market. Lilly, on the other hand, expects its sales to grow as much as 27% this year. - Chipotle Mexican Grill’s (CMG) doldrums are set to extend into 2026, with the burrito chain offering a full year-sales target that fell short of Wall Street’s expectations.Sales at established locations are expected to be “about flat” this year, Chipotle said in a statement Tuesday. That’s below the average of estimates compiled by Bloomberg and follows a decline in comparable sales in 2025 — the first time that’s happened since Chipotle became a public company.
Stock Movers